ET
RYTM icon

Entropy Technologies’s Rhythm Pharmaceuticals RYTM Stock Holding History

Entropy Technologies’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$897K Buy
10,318
+7,826
+314% +$761K 0.04% 439
2025
Q4 		$267K Sell
2,492
-6,010
-71% -$638K 0.01% 734
2025
Q3 		$859K Buy
+8,502
New +$789K 0.06% 363
2025
Q2 		– Sell
-5,502
Closed -$291K – 987
2025
Q1 		$291K Buy
+5,502
New +$305K 0.03% 545

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Entropy Technologies's RYTM Position: Q1 2026 in Review

Entropy Technologies increased its Rhythm Pharmaceuticals (RYTM) stake by 314% in Q1 2026, buying an estimated $761K and bringing the position to 10,318 shares worth $897K. The position accounts for 0.04% of the portfolio, ranked #439.

Entropy Technologies first reported a position in RYTM in Q1 2025 and has held it in 4 quarters since. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Entropy Technologies held 10,318 shares of Rhythm Pharmaceuticals worth $897K as of Q1 2026.
  • Entropy Technologies bought 7,826 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $761K.
  • Rhythm Pharmaceuticals made up 0.04% of Entropy Technologies's portfolio in Q1 2026, its #439 holding.
  • Entropy Technologies first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.